# GHK-Cu Research: Genes, Neuroprotection, Wound Repair and Mechanism > GHK-Cu shifts expression of roughly 31% of human genes toward repair, upregulates 408 neuron-associated genes, and improved cognition in aged and Alzheimer-model mice given intranasal GHK. The cited research record. The mechanism, the gene-expression breadth, the neuroprotective rodent work, and the wound- and inflammation data — each specimen pinned to its primary source, with the human-data gaps named in the margin. ## GHK-Cu research begins at the copper-binding site GHK-Cu research opens with a structural fact: a single copper(II) ion held by glycyl-histidyl-lysine through three nitrogen donors — the histidine imidazole, the glycine alpha-amino, and the deprotonated glycine-histidine amide — leaving the lysine side chain free. That geometry gives the complex a copper stability constant near log K 16.4 and turns it into both a copper chaperone and a pleiotropic signal [6]. The copper is not incidental — strip it out and the free peptide no longer reproduces MMP-2 stimulation in fibroblasts [6]. The sequence is also endogenous. GHK occurs within the alpha-2(I) chain of type I collagen and in SPARC/osteonectin, and circulates in plasma, where it falls from about 200 ng/mL at age 20 to about 80 ng/mL by age 60 [3]. That detail frames the whole research program: the molecule is read as a signal the body liberates from its own matrix during repair, and loses with age. From that one binding event the documented effects radiate outward, the way a root system branches from a seed. The same molecule that cross-links collagen through lysyl oxidase also rebalances matrix metalloproteinases against their TIMP inhibitors, raises VEGF and FGF-2 to drive angiogenesis, suppresses NF-kB-driven inflammation, and shifts antioxidant gene programs through the Nrf2 axis [2][6]. The plates below follow that radiation from the cell to the whole organism. ## What Genes Does GHK-Cu Affect? ### What genes does GHK-Cu affect? Connectivity-Map analysis reports GHK shifts expression of about 31.2% of human genes at a 50%-or-greater threshold (59% up, 41% down), strongly stimulating the ubiquitin-proteasome system and DNA-repair and antioxidant sets [2], with 408 neuron-associated genes and 47 DNA-repair genes upregulated in nervous-system analysis [7]. The often-quoted "~4,000 genes" figure is an extrapolation; the verified threshold table reports on the order of 2,100 genes [2]. The pattern is coherent rather than random. The strongest single block is the ubiquitin-proteasome system — 41 genes up, 1 down [2] — the cell's protein-quality-control machinery, alongside DNA-repair and antioxidant programs. Read as a whole, the signature is a tilt toward maintenance and fidelity: remove damaged proteins, repair DNA, blunt oxidative stress. That is the mechanistic spine of the anti-aging thesis, and also its main caveat, because the genome-wide signature derives largely from Connectivity Map bioinformatics that still need protein-level in-vivo validation [2]. These gene programs map directly onto [what GHK-Cu has been studied for](/) elsewhere in this herbarium — matrix repair, angiogenesis and antioxidant defense — which is why one molecule recurs across the skin, hair, wound and neural plates. ## The Neuroprotective GHK-Cu Research ### What is the neuroprotective research on GHK-Cu? Gene-expression analysis reports GHK upregulates 408 neuron-associated genes and 47 DNA-repair genes [7], and intranasal GHK improved spatial memory while reducing the axonal-damage marker NFL-1 and the neuroinflammation marker MCP-1 in aged mice [8], and reduced amyloid burden in 5xFAD Alzheimer-model mice [9]. All neuroprotective evidence is rodent or in-silico/in-vitro; there is no human neurological trial. The rodent data is the newest branch of the herbarium and the most-watched. In 20-month-old C57BL/6 mice, intranasal GHK at 15 mg/kg daily for 8 weeks improved Y-maze and Box-maze performance versus saline and lowered NFL-1 in both sexes and MCP-1 in female frontal cortex [8]. In 5xFAD transgenic Alzheimer-model mice, intranasal GHK at 15 mg/kg three times weekly for 12 weeks improved the same behavioral measures, reduced amyloid plaque burden in frontal cortex and hippocampus, and again lowered MCP-1 [9]. Behavioral signals extend further down the literature: GHK and its analogs produced anxiolytic effects in rats [10], and the tripeptide reduced pain-induced aggressive-defensive behavior in a rat model [11]. ### Can GHK-Cu cross the blood-brain barrier? No human blood-brain-barrier penetration data exists. The rodent cognition studies that show CNS effects delivered GHK intranasally at 15 mg/kg [8][9], a route that bypasses the systemic circulation to reach the brain directly, rather than demonstrating passive blood-brain-barrier crossing. Both Tucker studies are preprints (bioRxiv), which is an additional reason to read the neuroprotection plate as a promising early specimen, not a settled finding. ## Can GHK-Cu Help With Wound Healing? ### Can GHK-Cu help with wound healing? GHK-Cu stimulates wound healing across numerous animal and human models, raising collagen, elastin, VEGF, FGF-2 and NGF while suppressing free radicals and TGF-beta-1 [6]; a biotinylated-GHK collagen matrix accelerated dermal wound healing in rats [12]. Wound repair is the oldest and best-replicated branch of the literature. The foundational tissue-remodeling review documents the full profile: increased synthesis of collagen, elastin, metalloproteinases, anti-proteases, VEGF, FGF-2, NGF, neurotrophins 3 and 4 and erythropoietin, alongside suppression of free radicals, thromboxane, oxidizing-iron release, TGF-beta-1, TNF-alpha and protein glycation, plus chemoattraction of macrophages, mast cells and capillary cells [6]. Biomaterial delivery extends this in vivo — a GHK-incorporated collagenous matrix served as a dermal-repair scaffold and accelerated healing in a rat wound model [12]. A topical wound-healing trial (CuHeal, NCT07437586) has been registered, but no completed systemic or injectable human trial exists. ## Does GHK-Cu Affect Inflammation? ### Does GHK-Cu affect inflammation? In tissue-remodeling research GHK-Cu suppresses free radicals, thromboxane, oxidizing-iron release, TGF-beta-1 and TNF-alpha while chemoattracting repair cells [6], consistent with an anti-inflammatory, antioxidant signaling profile across the reviewed models. At the pathway level the effect runs through NF-kB suppression and Nrf2/Keap1/HO-1 antioxidant activation [2]. The anti-inflammatory and pro-repair actions are two readings of one behavior. GHK-Cu does not simply shut inflammation down; it modulates TGF-beta context-dependently — pro-remodeling in an acute wound, anti-fibrotic where fibrosis is excessive — and pairs that with antioxidant gene induction [2][6]. That dual character is why the same molecule appears in both wound-acceleration and anti-fibrotic models. It also chemoattracts the repair cells an inflamed site needs — macrophages, mast cells and capillary cells [6] — so the signal reads less as suppression than as a redirection of the response toward resolution. ## Is GHK-Cu Really Anti-Aging? ### Is GHK-Cu peptide really anti-aging? Plasma GHK declines from about 200 ng/mL at age 20 to about 80 ng/mL by age 60 [3], and gene-expression work reports GHK shifts expression of roughly 31.2% of human genes toward repair, DNA-fidelity and antioxidant programs [2]. The anti-aging case is mechanistically broad but rests heavily on in-vitro and bioinformatic data from a single research lineage. The honest reading is that the mechanism is strong and the human outcome data is thin. The decline-with-age curve [3] and the genome-wide repair signature [2] make a compelling restorative narrative, and the topical skin trials supply real placebo-controlled human endpoints [3]. But the systemic anti-aging claim outruns its evidence: there are no human pharmacokinetic data, no completed systemic trials, and a large share of the foundational literature traces to Loren Pickart (1938-2023) and colleagues, so independent replication of the broader gene-expression and longevity claims remains limited. --- A night-herbarium of the GHK-Cu literature — each copper-tripeptide study pressed, labeled, and pinned to its source, with no clinic behind the specimen sheet and nothing here for sale.